Pharmaceutical combination for the prophylaxis and therapy of malaria
US5219865A · kind A · utility
6Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 1992 |
| Grant date | Jun 15, 1993 |
| Priority date | — |
| Expiry date | Apr 9, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to combinations of the malaria therapeutics artemisinine, dihydroartemisinine, arteether, artemether, artesunate or other artemisinine derivatives with one or more of the antimalarials chloroquine, 10-0-methylfloxacrine, quinine, mefloquine, amodiaquine, pyrimethamine, sulfadoxine and primaquine. Synergistic actions are achieved with them on treatment of mammals, including humans, with subcurative doses of the individual substances.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.